{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:37:02Z","timestamp":1780389422396,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study compares the management and outcome of high grade squamous intraepithelial lesions (HSIL) in HIV-positive and -negative women and identifies risk factors for treatment failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective, controlled study includes 146 HIV-positive women, matched for HSIL, age and year of diagnosis, with 146 HIV-negative women. Differences were analysed using parametric and non-parametric tests and Kaplan\u2013Meier survival curves. A binary logistic regression was used to assess risk factors for treatment failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Persistence of cervical disease was observed most frequently in HIV-positive women (42 versus 17%) (p \u2009&lt;\u2009 0.001) and the cone biopsy margins were more often invaded in HIV-positive-women than in HIV-negative ones. (37 versus 16%; p \u2009&lt;\u2009 0.05).<\/jats:p>\n                <jats:p>HIV-positive women, with successful cervical treatment had better HIV disease control: with significantly longer periods of undetectable HIV viral loads (VL) (19 versus 5\u00a0months; p \u2009&lt;\u2009 0.001) and higher CD4 counts (491 versus 320\u00a0cells\/mm<jats:sup>3<\/jats:sup>; p \u2009&lt;\u2009 0.001). HIV-positive women with detectable VL at the time of dysplasia had 3.5 times (95% IC: 1.5\u20138.3) increased risk of treatment failure. Being treated through ablative therapy was associated with a 7.4, four-fold (95% IC: 3.2\u201317.3) increased risk of treatment failure compared to conization<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>HIV-positive women have a higher risk of treatment failure of HSIL than do HIV-negative women, especially when ablative therapy is used and in women with poor control of their HIV infection. The management and the follow- up of HSIL\u2019s guidelines in this high-risk population should be adapted consequently: for HIV-positive women with uncontrolled viral load, excisional treatment should be the preferred therapy, whereas for women with undetectable viral load, CD4 \u2009+\u2009 lymphocytes higher than 500\u00a0cells\/mm<jats:sup>3<\/jats:sup> and with a desire of pregnancy, ablative therapy may be considered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12981-021-00371-x","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T17:03:02Z","timestamp":1627059782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Should the management of high grade cervical squamous intraepithelial lesion (HSIL) be different in HIV-positive women?"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4738-5924","authenticated-orcid":false,"given":"Christine","family":"Gilles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Velghe-lenelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Manigart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9borah","family":"Konopnicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Rozenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"371_CR1","unstructured":"UNAIDS. Aids by the Numbers 2018. https:\/\/www.unaids.org\/en\/resources\/documents\/2019\/aids-by-the-numbers. Accessed 2 June 2020."},{"key":"371_CR2","unstructured":"https:\/\/www.who.int\/cancer\/prevention\/diagnosis-screening\/cervical-cancer\/en\/. Accessed 2 June 2020."},{"issue":"6","key":"371_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jama.1993.03500060023008","volume":"269","author":"From the Centers for Disease Control and Prevention","year":"1993","unstructured":"From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA. 1993;269(6):729.","journal-title":"JAMA"},{"key":"371_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-3-030-03502-0_5","volume":"177","author":"P Du","year":"2019","unstructured":"Du P. Human papillomavirus infection and cervical cancer in HIV+ women. Cancer Treat Res. 2019;177:105\u201329.","journal-title":"Cancer Treat Res"},{"issue":"6","key":"371_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","volume":"32","author":"G Liu","year":"2018","unstructured":"Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS. 2018;32(6):795\u2013880.","journal-title":"AIDS"},{"issue":"3","key":"371_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/0956462413491735","volume":"25","author":"SA Denslow","year":"2014","unstructured":"Denslow SA, Rositch AF, Firnhaber C, Ting J, Smith JS. Incidence and progression of cervical lesions in women with HIV: a systematic global review. Int J STD AIDS. 2014;25(3):163\u201377.","journal-title":"Int J STD AIDS"},{"key":"371_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ygyno.2004.10.003","volume":"96","author":"C Gilles","year":"2005","unstructured":"Gilles C, Manigart Y, Konopnicki D, Barlow P, Rozenberg S. Management and outcome of cervical intraepithelial neoplasia lesions: a study of matched cases according to HIV status. Gynecol Oncol. 2005;96:112\u20138.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"371_CR8","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/cid\/ciy1123","volume":"69","author":"P Debeaudrap","year":"2019","unstructured":"Debeaudrap P, Sobngwi J, Tebeu PM, Clifford GM. Residual or recurrent precancerous lesions after treatment of cervical lesions in human immunodeficiency virus-infected women: a systematic review and meta-analysis of treatment failure. Clin Infect Dis. 2019;69(9):1555\u201365.","journal-title":"Clin Infect Dis"},{"key":"371_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2147\/PPA.S192735","volume":"13","author":"F Altice","year":"2019","unstructured":"Altice F, Evuarherhe O, Shina S, Carter G, Beaubrun AC. Adherence to HIV treatment regimens: systematic literature review and meta-analysis. Patient Prefer Adherence. 2019;13:475\u201390. https:\/\/doi.org\/10.2147\/PPA.S192735 (PMID: 31040651).","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"371_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijgo.2015.07.038","volume":"132","author":"N Santesso","year":"2016","unstructured":"Santesso N, Mustafa RA, Sch\u00fcnemann HJ, et al. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2\u20133 and screen-and-treat strategies to prevent cervical cancer. Int J Gynaecol Obstet. 2016;132(3):252\u20138. https:\/\/doi.org\/10.1016\/j.ijgo.2015.07.038.","journal-title":"Int J Gynaecol Obstet"},{"key":"371_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/GMIT.GMIT_56_18","volume":"7","author":"P D'Alessandro","year":"2018","unstructured":"D\u2019Alessandro P, Arduino B, Borgo M, et al. Loop electrosurgical excision procedure versus cryotherapy in the treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of randomized controlled trials. Gynecol Minim Invasive Ther. 2018;7:145\u201351.","journal-title":"Gynecol Minim Invasive Ther"},{"key":"371_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00128360-200301000-00005","volume":"7","author":"ZM Chirenje","year":"2003","unstructured":"Chirenje ZM, Rusakaniko S, Akino V, Munjoma M, Mlingo M. Effect of HIV disease in treatment outcome of cervical squamous intraepithelial lesions among Zimbabwean women. J Low Genit Tract Dis. 2003;7:16\u201321.","journal-title":"J Low Genit Tract Dis"},{"key":"371_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1001\/jama.2019.14969","volume":"322","author":"SA Greene","year":"2019","unstructured":"Greene SA, De Vuyst H, John-Stewart GC, et al. Effect of cryotherapy vs loop electrosurgical excision procedure on cervical disease recurrence among women with HIV and high-grade cervical lesions in Kenya: a randomized clinical trial. JAMA. 2019;322:1570.","journal-title":"JAMA"},{"key":"371_CR14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2017.03.022","volume":"217","author":"JS Smith","year":"2017","unstructured":"Smith JS, Sanusi B, Swarts A, et al. A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy versus loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa. Am J Obstet Gynecol. 2017;217:e1-11.","journal-title":"Am J Obstet Gynecol"},{"key":"371_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa238","author":"N Atemnkeng","year":"2020","unstructured":"Atemnkeng N, Desmond A, de Sanjose S, Mayaud P. Kelly H Antiretroviral therapy and detection of high-grade cervical intraepithelial neoplasia (CIN2+) at post-CIN management follow-up among women living with HIV: a systematic review and meta-analysis. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa238.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"371_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","volume":"24","author":"RB Perkins","year":"2020","unstructured":"Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. J Low Genit Tract Dis. 2020;24(2):102.","journal-title":"J Low Genit Tract Dis"},{"key":"371_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/ijc.32260","volume":"146","author":"E Rohner","year":"2020","unstructured":"Rohner E, B\u00fctikofer L, Schmidlin K, et al. Cervical cancer risk in women living with HIV across four continents: a multicohort study. Int J Cancer. 2020;146:601\u20139.","journal-title":"Int J Cancer"},{"key":"371_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ygyno.2018.08.033","volume":"151","author":"A Ghelardi","year":"2018","unstructured":"Ghelardi A, Parazzini F, Martella F, Pieralli A, Bay P, Tonetti A, Svelato A, Bertacca G, Lombardi S, Joura EA. SPERANZA project: HPV vaccination after treatment for CIN2. Gynecol Oncol. 2018;151:229\u201334. https:\/\/doi.org\/10.1016\/j.ygyno.2018.08.033.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"371_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ygyno.2013.04.050","volume":"130","author":"WD Kang","year":"2013","unstructured":"Kang WD, Choi HS. Kim SM Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol Oncol. 2013;130(2):264\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2013.04.050 (PMID: 23623831).","journal-title":"Gynecol Oncol"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-021-00371-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-021-00371-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-021-00371-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T17:08:40Z","timestamp":1627060120000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-021-00371-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["371"],"URL":"https:\/\/doi.org\/10.1186\/s12981-021-00371-x","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]},"assertion":[{"value":"11 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved on March 20th, 2018 by the Saint-Pierre University Hospital Ethical Review Board (nr CE\/18-03-08). Consent to participate is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}